MBP 3.23% 3.0¢ metabolic pharmaceuticals limited

target price 22 cents, page-21

  1. 13,013 Posts.
    lightbulb Created with Sketch. 99
    re: syringe***big investor backup*** Despite all the kicking around this stock has received, the fact remains that there is still a good deal of uncertainty about its potential. My belief is that it will eventually stabilise and that will represent a good opportunity for those who are prepared to accept the risk which in my view is around 50:50. The potential for upside will be significant.
 
watchlist Created with Sketch. Add MBP (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.